Harrow Inc. (HROW), an eyecare pharmaceutical company, Thursday said ImprimisRx, a unit of Harrow, has won the trademark infringement case against OSRX, Inc. and its related party Ocular Science, Inc.
ImprimisRx had alleged trademark infringement against OSRX and Ocular Science.
The $34.9 million verdict by the United States District Court for the Southern District of California includes $20.4 million in punitive damages and $14.5 million in actual damages.
The court observed that OSRX, or Ocular Science willfully engaged in trademark infringement.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.